Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor

Cytotherapy

Volumn 16, Issue 8, 2014, Pages 1117-1120

  Donia, Marco ^a,b,c   Larsen, Signe Møllebæk ^a   Met, Özcan ^a,b   Svane, Inge Marie ^a,b  

^a Center for Cancer Immune Therapy   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Metastatic melanoma; Rapid expansion; Tumor infiltrating lymphocytes; Wave bioreactor

Indexed keywords

ARTICLE; BIOREACTOR; CELL CULTURE; CELL EXPANSION; CELL MANIPULATION; CLINICAL PROTOCOL; CONTROLLED STUDY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; TUMOR ASSOCIATED LEUKOCYTE; ADOPTIVE IMMUNOTHERAPY; BIOLOGICAL THERAPY; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOLOGY; GENETICS; HUMAN; MELANOMA; METASTASIS; PATHOLOGY;

BIOREACTORS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; NEOPLASM METASTASIS;

EID: 84903820103     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.02.004     Document Type: Article

References (16)

1. June C., Rosenberg S.A., Sadelain M., Weber J.S. T-cell therapy at the threshold. Nature Biotechnol 2012, 30:611-614.
2. Radvanyi L.G., Bernatchez C., Zhang M., Fox P., Miller P., Chacon J., et al. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 2012, 18:6758-6770.
3. Ellebaek E., Iversen T.Z., Junker N., Donia M., Engell-Noerregaard L., Met O., et al. Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose interleukin-2 in metastatic melanoma patients. JTransl Med 2012, 10:169.
4. Dudley M.E., Yang J.C., Sherry R., Hughes M.S., Royal R., Kammula U., et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. JClin Oncol 2008, 26:5233-5239.
5. Itzhaki O., Hovav E., Ziporen Y., Levy D., Kubi A., Zikich D., et al. Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy. JImmunother 2011, 34:212-220.
6. Pilon-Thomas S., Kuhn L., Ellwanger S., Janssen W., Royster E., Marzban S., et al. Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma. JImmunother 2012, 35:615-620.
7. June C.H. Adoptive T cell therapy for cancer in the clinic. JClin Invest 2007, 117:1466-1476.
8. Somerville R.P.T., Devillier L., Parkhurst M.R., Rosenberg S.A., Dudley M.E. Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE bioreactor. JTransl Med 2012, 10:69.
9. Hollyman D, Stefanski J, Przybylowski M, Bartido S, Borquez-Ojeda O, Taylor C, etal. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. J Immunother. 2009;32:169-180.
10. Hami L.S., Green C., Leshinsky N., Markham E., Miller K., Craig S. GMP production and testing of Xcellerated T cells for the treatment of patients with CLL. Cytotherapy 2004, 6:554-562.
11. Sadeghi A., Pauler L., Annerén C., Friberg A., Brandhorst D., Korsgren O., et al. Large-scale bioreactor expansion of tumor-infiltrating lymphocytes. JImmunol Methods 2011, 364:94-100.
12. Donia M., Junker N., Ellebaek E., Andersen M.H., Straten P.T., Svane I.M. Characterization and comparison of "standard" and "young" tumor infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution. Scand J Immunol 2011, 75:157-167.
13. Dudley M.E., Wunderlich J.R., Shelton T.E., Even J., Rosenberg S.A. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. JImmunother 2003, 26:332-342.
14. Schallmach E., Sareli R., Besser M.J., Leipsiger S., Hardan I., Treves A.J., et al. Collection of large-scale expanded lymphocyte cultures for adoptive immunotherapy using a COBE Spectra apheresis machine. JImmunother 2008, 31:563-568.
15. Klebanoff C.A., Gattinoni L., Palmer D.C., Muranski P., Ji Y., Hinrichs C.S., et al. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice. Clin Cancer Res 2011, 17:5343-5352.
16. Besser M.J., Shapira-Frommer R., Itzhaki O., Treves A.J., Zippel D., Levy D., et al. Adoptive transfer of tumor infiltrating lymphocytes in metastatic melanoma patients: intent-to-treat analysis and efficacy after failure to prior immunotherapies. Clin Cancer Res 2013.